The Scientist - Home

The study, conducted in Malawi, Kenya, and Ghana, did not obtain informed consent from each parent whose child participated, but rather considered consent “implied” because of the particular experimental design.

Aripiprazole, marketed as Abilify, is widely thought to be safer than risperidone, the only other drug approved for use in autistic children. A decade’s worth of data suggests that is not true.

A patient in California acquired COVID-19 despite not traveling to an affected area or having contact with anyone who did.

The sponsors of upwards of 1,000 clinical trials may be forced to publish data that have gone unpublished over a 10-year period.

Researchers can print cells and biomaterials that make up human tissues, but there’s still a long way to go before fully functional organs can be made to order.

When the sun’s atmosphere is stormy, more whales end up on the beach, according to a new study. Biologists speculate it may have to do with navigation or health.

Organizers have cancelled conferences, COVID-19 quarantines have prevented some scientists in China from visiting their labs, and travel restrictions have left researchers stranded.

Random mutations in the SARS-CoV-2 pathogen’s genome help researchers track the spread and transmission of COVID-19, the disease it causes.

The 1-billion-year-old impressions have features similar to modern algae and indicate that photosynthesizing plants evolved at least that long ago.

The embattled organization is left with only one member of the leadership—the group’s founder, BethAnn McLaughlin, who is accused of bullying.

Brain banks have struggled to convince unaffected individuals to donate, hampering studies on “cognitively normal” neurodevelopment and aging.

Draconian drug laws harm citizens the world over. It’s high time to use sound science to change the landscape of prohibition.